Dr Martens has reported a droop in earnings regardless of hitting a £1bn income milestone for the primary time - after admitting it made errors in opposition to the backdrop of "a challenging consumer environment".

The footwear agency reported pre-tax earnings of £159m for the 12 months ending 31 March, a fall of 26% on the 12 months earlier than.

The British model stated it had made a number of "operational mistakes", together with with advertising campaigns, which it stated had been "too focused on shoes and sandals" to the detriment of its boots.

This doubtless contributed to a ten% fall in boots income, the corporate stated, whereas it additionally blamed e-commerce points and world distribution issues, significantly with a brand new warehouse in Los Angeles.

However, the model stated many errors had now been "corrected" and it was fixing different excellent points.

The firm stated that whereas enterprise within the US had been weak, its efficiency in Europe, the Middle East and Africa (EMEA) and Japan had been "very good".

Read extra from enterprise:'Storm clouds gathering' for property marketAmazon to pay millions to settle doorbell privacy claims

Chief government officer Kenny Wilson hailed the corporate's achievement in reaching £1bn in income.

He stated: "Reaching this milestone is testomony to the energy of our model, our long-standing technique and the onerous work and dedication of our implausible individuals globally.

"Direct to consumer is now more than half our revenue and the Dr Martens brand remains strong with all key metrics either ahead of, or in line with, last year."

But the model additionally warned of decrease upcoming earnings.

It expects its full-year earnings earlier than curiosity, tax, depreciation and amortisation (EBITDA) margin to be one to 2 proportion factors decrease than the reported 12 months.

Its shares have been down as a lot as 11.7% in early buying and selling on Thursday - its worst day in over 4 months.

Dr Martens made its London stock market debut in January 2021.